2nd Quarter - Report

INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

IPC supports S.127 Pharmacy Benefit Manager Transparency Act of 2023. IPC supports S.113 Prescription Pricing for the People Act of 2023. IPC supports H.R. 1770 Equitable Community Access to Pharmacists Services Act of 2023. IPC supports the Inflation Reduction Act of 2022 and CMS implementation. IPC supports H.R. 1613 Drug Price Transparency in Medicaid Act of 2023. IPC supports S. 1038 Drug Price Transparency in Medicaid Act of 2023 IPC opposes S. 1339 Pharmacy Benefits Reform Act - because it may preempt state PBM laws relating to ERISA. IPC supports H.R. 3561 Promoting Access to Treatments and Increasing Extremely Needed Transparent (PATIENT) Act of 2023 IPC supports S. 1491 Pharmacy and Medically Underserved Areas Enhancement Act

LobbyistCovered position, as disclosed
JOHN A. COVELLO —
MARK EUGENE KINNEY —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); SENATE

Bills named: S. 127 (118th), S. 1491 (118th), H.R. 3561 (118th), S. 1038 (118th), S. 113 (118th), H.R. 1770 (118th), S. 1339 (118th), H.R. 1613 (118th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.